Show simple item record

dc.contributor.authorGago, S.
dc.contributor.authorOverton, Nicola L D
dc.contributor.authorBowyer, P.
dc.date.accessioned2021-01-25T01:13:49Z
dc.date.available2021-01-25T01:13:49Z
dc.date.issued2021en
dc.identifier.citationGago S, Overton NLD, Bowyer P. CRISPR-Cas9-Mediated Gene Silencing in Cultured Human Epithelia. Methods Mol Biol. 2021;2260:37-47.en
dc.identifier.pmid33405030en
dc.identifier.doi10.1007/978-1-0716-1182-1_4en
dc.identifier.urihttp://hdl.handle.net/10541/623739
dc.description.abstractCRISPR/Cas9 technology enables rapid and efficient genome editing in a variety of experimental systems. Genome editing using CRISPR/Cas9 has become an increasingly popular genetic engineering tool due to (1) an extensive array of commercial ready-to-use CRIPSR/Cas9 systems, (2) improved efficiency of cell delivery, and (3) the possibility to do multigene editing. Here, we describe a method to introduce single gene disruption in lung bronchial epithelial cells. This approach can be used to study host factors important for pathogen interaction or to identify and study genetic markers determining susceptibility to fungal disease.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1007/978-1-0716-1182-1_4en
dc.titleCRISPR-Cas9-mediated gene silencing in cultured human epitheliaen
dc.typeArticleen
dc.contributor.departmentManchester Fungal Infection Group, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Core Technology Facility, The University of Manchester, Manchester, UK.en
dc.identifier.journalMethods in Molecular Biologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record